NeuroVive Pharmaceutical AB Enrolls First Patient in Clinical Phase 2 Study for Kidney Protection During Cardiac Surgery
NeuroVive Pharmaceutical AB recently announced the enrollment of its first patient in a clinical phase II trial that will evaluate the potential of CicloMulsion® (ciclosporin) to reduce the risk and degree of acute ... Read more